ALXN News and Press, Alexion Pharmaceuticals Inc. From 07/26/21

Zoom uses its expensive stock to enter adjacent market with the acquisition of Five9 for $14.7 billion. Monmouth Real Estate Investment Corporation's board supports the pending merger of MNR with Equity Commonwealth after receiving a competing offer from Starwood. Salesforce compl...

Lisa Maree Williams/Getty Images News AstraZeneca (AZN) announces that Alexion’s (ALXN) Ultomiris (ravulizumab) has been recommended for marketing authorization in the European Union ((EU)) for expanded use to include children and adolescents with paroxysmal nocturnal haemoglobinuria (...

AstraZeneca (NASDAQ: AZN) hopes to soon close its planned acquisition of Alexion Pharmaceuticals (NASDAQ: ALXN) . The only hurdle left to jump is obtaining approval from United Kingdom regulators. In this Motley Fool Live video recorded on July 7 , Motley Fool contri...

This week, pharma and biotech giant AstraZeneca (NASDAQ: AZN) cleared its final hurdle in the proposed acquisition of orphan drug pharma company Alexion Pharmaceuticals (NASDAQ: ALXN) when it announced that the deal had received clearance from the United Kingdom's Compet...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips The economy is not letting inflation get to it. Consumer spending is ramping up, even in the face of inflated prices, and helping to speed up on the road to recovery. Meanwhile, vaccine company Moderna (NASDAQ: MRNA )...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Moderna (NASDAQ: MRNA ) stock is on the rise Friday as the company prepares to join the S&P 500 . Source: Shutterstock MRNA stock is set to join the S&P 500 before trading starts on Wednesday . The r...

Orientfootage/iStock via Getty Images Earnings-related news remained a key theme on Friday. Ericsson (ERIC) dropped in pre-market action on a disappointing quarterly report. Molson Coors (TAP)(TAP.A) ticked up after it reaffirmed its forecast and reinstated its dividend. In other news, MoneyG...

Moderna Set to Join S&P 500 Moderna Set to Join S&P 500 PR Newswire NEW YORK , July 15, 2021 /PRNewswire/ -- Moderna Inc. (NASD:MRNA) will replace Alexion Pharmaceuticals Inc. (NASD:ALXN) in the S&P 500 effective prior to the opening of trading on...

– Study met primary endpoint of change from baseline in the Myasthenia Gravis-Activities of Daily Living Profile (MG-ADL) total score at Week 26 – – ULTOMIRIS demonstrated compelling efficacy as early as Week 1, sustained for 52 weeks – ...

Zhanna Hapanovich/iStock via Getty Images After the U.K. Competition and Markets Authority greenlighted the proposed acquisition of Alexion Pharmaceuticals (ALXN) by AstraZeneca (AZN), the deal is expected to close on July 21 after which Alexion shares will be delisted from Nasdaq, the exchan...